Hideya Onishi

3.2k total citations
113 papers, 2.6k citations indexed

About

Hideya Onishi is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Hideya Onishi has authored 113 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 50 papers in Molecular Biology and 41 papers in Immunology. Recurrent topics in Hideya Onishi's work include Immunotherapy and Immune Responses (28 papers), Hedgehog Signaling Pathway Studies (27 papers) and Epigenetics and DNA Methylation (21 papers). Hideya Onishi is often cited by papers focused on Immunotherapy and Immune Responses (28 papers), Hedgehog Signaling Pathway Studies (27 papers) and Epigenetics and DNA Methylation (21 papers). Hideya Onishi collaborates with scholars based in Japan, United States and Russia. Hideya Onishi's co-authors include Mitsuo Katano, Takashi Morisaki, Masao Tanaka, Akio Yamasaki, Makoto Kubo, Haruo Tanaka, Masafumi Nakamura, Junji Wada, Masayo Umebayashi and Kenji Nakano and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Hideya Onishi

112 papers receiving 2.6k citations

Peers

Countries citing papers authored by Hideya Onishi

Since Specialization

Citations

This map shows the geographic impact of Hideya Onishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideya Onishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideya Onishi more than expected).

Fields of papers citing papers by Hideya Onishi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideya Onishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideya Onishi. The network helps show where Hideya Onishi may publish in the future.

Co-authorship network of co-authors of Hideya Onishi

This figure shows the co-authorship network connecting the top 25 collaborators of Hideya Onishi. A scholar is included among the top collaborators of Hideya Onishi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideya Onishi. Hideya Onishi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neoantigen peptide-pulsed dendritic cell vaccine therapy after surgical treatment of pancreatic cancer: a retrospective study 2025 ·Frontiers in Immunology ·(unknown), Kohei Nakata, Toshiya Abe, (unknown), Nao Fujimori, Kazuma Kiyotani, Chika Iwamoto, Naoki Ikenaga, (unknown), Masayo Umebayashi, Hiroto Tanaka, (unknown), Shinichiro Nakagawa, (unknown), (unknown), Hideya Onishi, Yusuke Nakamura, Masafumi Nakamura, Takashi Morisaki	5
2	Modulation of allograft immune responses by Porphyromonas gingivalis lipopolysaccharide administration in a rat model of kidney transplantation 2024 ·Scientific Reports ·Yu Sato, Hiroshi Noguchi, (unknown), (unknown), Yasuhiro Okabe, Hideya Onishi, Masafumi Nakamura	1
3	Immunological analysis of hybrid neoantigen peptide encompassing class I/II neoepitope-pulsed dendritic cell vaccine 2023 ·Frontiers in Immunology ·(unknown), Hideya Onishi, (unknown), Makoto Kubo, Masayo Umebayashi, (unknown), (unknown), Shinichiro Nakagawa, (unknown), (unknown), Poh Yin Yew, Kazuma Kiyotani, Yusuke Nakamura, Masafumi Nakamura, Takanari Kitazono, Takashi Morisaki	5
4	Effects of periodontal pathogen-induced intestinal dysbiosis on transplant immunity in an allogenic skin graft model 2023 ·Scientific Reports ·(unknown), Hiroshi Noguchi, Ryutaro Kuraji, (unknown), (unknown), (unknown), Yasuhiro Okabe, Hideya Onishi, Masafumi Nakamura	9
5	Biological and genetic characterization of a newly established human external auditory canal carcinoma cell line, SCEACono2 2023 ·Scientific Reports ·Noritaka Komune, Kuniaki Sato, Mayumi Ono, Akira Imaizumi, (unknown), (unknown), (unknown), (unknown), Takahiro Hongo, Ryunosuke Kogo, Hideya Onishi, Takashi Nakagawa	0
6	Contribution of pre-existing neoantigen-specific T cells to a durable complete response after tumor-pulsed dendritic cell vaccine plus nivolumab therapy in a patient with metastatic salivary duct carcinoma 2021 ·Immunological Investigations ·(unknown), Akiko Fujimura, Muneyuki Masuda, (unknown), Ryuji Yasumatsu, Masayo Umebayashi, (unknown), (unknown), Shinichiro Nakagawa, Poh Yin Yew, (unknown), Hideya Onishi, Masafumi Nakamura, Yusuke Nakamura, Takashi Morisaki	11
7	Establishment and characterization of a primary cell culture derived from external auditory canal squamous cell carcinoma 2021 ·FEBS Open Bio ·(unknown), Akira Imaizumi, Noritaka Komune, Mayumi Ono, Kuniaki Sato, (unknown), Akiko Fujimura, (unknown), Takahiro Hongo, Ryutaro Uchi, Hideya Onishi, Takashi Nakagawa	4
8	ERAP2 is a novel target involved in autophagy and activation of pancreatic stellate cells via UPR signaling pathway 2021 ·Pancreatology ·(unknown), Kohei Nakata, (unknown), Chika Iwamoto, Sho Endo, (unknown), (unknown), Naoki Ikenaga, Koji Shindo, Taiki Moriyama, Hideya Onishi, Kenoki Ohuchida, Yoshinao Oda, Masafumi Nakamura	11
9	Efficacy of Intranodal Neoantigen Peptide-pulsed Dendritic Cell Vaccine Monotherapy in Patients With Advanced Solid Tumors: A Retrospective Analysis 2021 ·Anticancer Research ·Takashi Morisaki, Takafumi Morisaki, Makoto Kubo, Hideya Onishi, (unknown), (unknown), Masatoshi Eto, (unknown), Ario Takeuchi, Shinichiro Nakagawa, (unknown), (unknown), Masayo Umebayashi, (unknown), Poh Yin Yew, (unknown), Kazuma Kiyotani, Yusuke Nakamura	10
10	Intranodal Administration of Neoantigen Peptide-loaded Dendritic Cell Vaccine Elicits Epitope-specific T Cell Responses and Clinical Effects in a Patient with Chemorefractory Ovarian Cancer with Malignant Ascites 2020 ·Immunological Investigations ·Takashi Morisaki, (unknown), Hideya Onishi, Takafumi Morisaki, Makoto Kubo, (unknown), (unknown), Kazuma Kiyotani, Yusuke Nakamura	30
11	Liprin-alpha4 contributes to increased proliferation and decreased chemosensitivity under hypoxia for small cell lung cancer as a downstream mediator of HIF-1alphaα 2018 ·Annals of Oncology ·Hideya Onishi, Akio Yamasaki, Makoto Kawamoto	1
12	Liprin-α4 as a Possible New Therapeutic Target for Pancreatic Cancer 2017 ·Anticancer Research ·Akio Yamasaki, (unknown), Akira Imaizumi, Makoto Kawamoto, Akiko Fujimura, (unknown), Shuntaro Nagai, Kosuke Yanai, Hideya Onishi	12
13	TrkB/BDNF signaling promotes EMT mediated invasiveness and is a potential therapeutic target for gallbladder cancer 2016 ·Annals of Oncology ·Makoto Kawamoto, Hideya Onishi, Keigo Ozono, Akio Yamasaki, Akira Imaizumi, Masaya Nakamura	3
14	Hedgehog signaling regulates PDL-1 expression in cancer cells to induce anti-tumor activity by activated lymphocytes 2016 ·Cellular Immunology ·Hideya Onishi, Akiko Fujimura, (unknown), Akio Yamasaki, Akira Imaizumi, Makoto Kawamoto, Mitsuo Katano, Masayo Umebayashi, Takashi Morisaki	26
15	A new method for rapid cytotoxic T-lymphocyte induction using a multiple cytokine cocktail. 2012 ·PubMed ·Hideya Onishi, (unknown), (unknown), Hiroto Tanaka, Masayo Umebayashi, Mitsuo Katano, Takashi Morisaki	4
16	Hedgehog inhibitor decreases chemosensitivity to 5‐fluorouracil and gemcitabine under hypoxic conditions in pancreatic cancer 2012 ·Cancer Science ·Hideya Onishi, (unknown), Masaya Kai, (unknown), Hironori Iwasaki, Mitsuo Katano	39
17	Hedgehog signaling pathway as a therapeutic target in various types of cancer 2011 ·Cancer Science ·Hideya Onishi, Mitsuo Katano	81
18	Evaluation of a dysfunctional and short-lived subset of monocyte-derived dendritic cells from cancer patients. 2005 ·PubMed ·Hideya Onishi, Takashi Morisaki, (unknown), Kotaro Matsumoto, Eishi Baba, (unknown), Masao Tanaka, Mitsuo Katano	4
19	Combination of adoptive immunotherapy with Herceptin for patients with HER2-expressing breast cancer. 2004 ·PubMed ·Makoto Kubo, Takashi Morisaki, (unknown), Akira Tasaki, Naoki Yamanaka, Kotaro Matsumoto, Katsuya Nakamura, Hideya Onishi, Eishi Baba, Mitsuo Katano	25
20	[Immunohistochemical study of PCNA, EGFR, c-erbB-2 and p53 in carcinomas of large intestine]. 1995 ·PubMed ·H Yamagiwa, Naoaki Onishi, Toru Onishi, Hideya Onishi, Kazuhiro Watanabe, Yoshihiko Kadowaki, (unknown), Yukio Kato	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact